Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Phase NA Unknown
360 enrolled
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Phase 3 Unknown
316 enrolled
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
Phase 2 Unknown
57 enrolled
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Phase 2 Unknown
50 enrolled
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Phase 2 Unknown
200 enrolled
Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 2 Unknown
39 enrolled
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Phase 2 Unknown
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
Phase 2 Unknown
Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
Phase 3 Unknown
200 enrolled
SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Phase 3 Unknown
Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
Phase 3 Unknown
150 enrolled
Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
Phase 3 Unknown
Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 2 Unknown
Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Phase 3 Unknown
1,800 enrolled
Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 3 Unknown
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 2 Unknown
Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Phase 3 Unknown
300 enrolled
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Phase 3 Unknown
700 enrolled
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
Phase 3 Unknown
120 enrolled
Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
Phase 1/2 Unknown
40 enrolled
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
Phase 1/2 Unknown
46 enrolled
Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer
Phase 2 Unknown
20 enrolled
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
Phase 1/2 Unknown
Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
Phase 3 Unknown
240 enrolled
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
Phase 3 Unknown
750 enrolled
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
Phase 3 Unknown
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
Phase 3 Unknown
Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin
Phase 3 Unknown
400 enrolled
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
Phase 2 Unknown
50 enrolled
Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy
Phase 2 Unknown
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
Phase 1 Unknown
30 enrolled
Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Phase 1 Unknown
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
Phase 3 Unknown
220 enrolled
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
Phase 2 Unknown
50 enrolled
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
Phase 3 Unknown
105 enrolled
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Phase 2 Unknown
29 enrolled
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
Phase 2 Unknown
47 enrolled
Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma
Phase 3 Unknown
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
Phase NA Unknown
120 enrolled
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
Phase 2 Unknown
87 enrolled
Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 3 Unknown
1,350 enrolled
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
Phase 2 Unknown
50 enrolled
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus
Phase NA Unknown
160 enrolled
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Phase 2 Unknown
60 enrolled
Combination Chemotherapy in Treating Patients With Esophageal Cancer
Phase 3 Unknown
1,300 enrolled
Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Phase 2 Unknown
170 enrolled
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
Phase 2 Unknown
47 enrolled
Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder
Phase 2 Unknown
45 enrolled
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 3 Unknown
326 enrolled